Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which breathing stops and starts repeatedly during sleep.

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the ...

Spirair, Inc., an early-stage company developing minimally invasive solutions to help ENTs improve patient care, today announced the publication of the first clinical study evaluating its SeptAligntm ...

Thousands to benefit as weight loss drug Mounjaro approved for new use - Australia and the United States have both approved ...

NEW YORK, DE, UNITED STATES, June 11, 2025 /EINPresswire.com/ -- The sleep apnea implants market generated USD 451.6 million ...

Scientists have discovered that people with COPD have lung cells that contain over three times as much soot-like carbon as ...

The new funding will support MOS118 through its Phase II development while expanding Mosanna's product pipeline.

Both continuous positive airway pressure (CPAP) and tirzepatide are acceptable treatments for comorbid obesity and ...

Precision medicine and phenotyping help tailor treatments to individual patient profiles.

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...